Skip to content
OpenCapital
Get started

Globus Medical GMED Enabling Technologies — Net Sales

Other product segments

Musculoskeletal Solutions
$732.98M—

Similar metrics at other companies

Baxter International logo
BAXAdvanced Surgery — Net Sales
$304M+13.4%
Baxter International logo
BAXSurgical Solutions — Net Sales
$77M+11.6%
Fortive logo
FTVMedical technologies — Sales
$308.1M+12.4%
Zimmer Biomet Holdings logo
ZBHTechnology And Data Bone Cement And Surgical — Revenue
$171.8M+14.6%
Baxter International logo
BAXPatient Support Systems — Net Sales
$359M-1.4%
Baxter International logo
BAXHealthcare Systems & Technologies — Net Sales
$705M+0.1%

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's enabling technologies — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's enabling technologies — net sales?
Globus Medical (GMED) reported enabling technologies — net sales of $26.87M in Q1 2026.
How has Globus Medical's enabling technologies — net sales changed year-over-year?
Globus Medical's enabling technologies — net sales increased by 21.1% year-over-year, from $22.19M to $26.87M.
What does enabling technologies — net sales mean?
The total revenue earned from selling advanced surgical robotics and navigation technology systems.
How do you interpret enabling technologies — net sales?
An increase indicates successful market adoption of the company's high-tech surgical platforms and growing demand for digital integration in operating rooms, while a decrease may signal market saturation, longer sales cycles for capital equipment, or increased competitive pressure.
How does enabling technologies — net sales compare across companies?
Comparable to revenue from robotics, digital surgery, or capital equipment segments at other medical technology firms, often evaluated based on the installed base growth and recurring service revenue potential.